Pandey Lab Publishes New Research on GEMIN5 Protein Implicated in Rare Neurodevelopmental Disorder

A research team from the Pandey Laboratory in the Division of Child Neurology at UPMC Children’s Hospital of Pittsburgh and the Department of Pediatrics at the University of Pittsburgh School of Medicine published their latest findings in their continuing investigations of GEMIN5-mediated neurodevelopmental disease.

Graduate researcher and PhD candidate, Tyler Fortuna, was the first author of the study, titled “SMN Regulates GEMIN5 Expression and Acts as a Modifier of GEMIN5-mediated Neurodegeneration,” published recently in Acta Neuropathologica. Udai Pandey, PhD, was the senior author.

For more details on the study and its findings, read a recent news post from the Department of Pediatrics at the University of Pittsburgh School of Medicine.

Learn more about the research of the Pandey Laboratory and the Children’s Neuroscience Institute.

Read more about Dr. Pandey and colleague’s research on GEMIN5 in a story on UPMC.com from 2021 summarizing their discovery of the genetic cause of the rare neurological disorder marked by developmental delay and ataxia.